Stock Screener App

Frei -

Installieren

1.29

0.00% 0.00

after-market

Handel nachbörslich: 1.29

Pliant Therapeutics Inc (PLRX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Pliant Therapeutics Inc-Aktie (PLRX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-09-30	2024-06-30	2024-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	22.64% 45.59	58.94	62.01	60.64	52.39
Operating Income/Loss	22.64% -45.59	-58.94	-62.01	-60.64	-52.39
Income/Loss From Continuing Operations Before Tax	22.91% -43.30	-56.17	-57.76	-55.85	-46.95
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	22.91% -43.30	-56.17	-57.76	-55.85	-46.95
Net Income/Loss	22.91% -43.30	-56.17	-57.76	-55.85	-46.95
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.27% 61.39	61.22	60.73	60.38	60.18
Diluted Average Shares	0.27% 61.39	61.22	60.73	60.38	60.18
Basic Earnings Per Share	22.83% -0.71	-0.92	-0.95	-0.92	-0.78
Diluted Earnings Per Share	22.83% -0.71	-0.92	-0.95	-0.92	-0.78
Common Stock Dividends	-	-	-	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.68

3.69%

MRNA

$53.83

6.87%

ROIV

$29.72

0.68%

BNTX

$101.95

1.78%

INSM

$143.57

4.21%

ONC

$292.94

2.03%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters